Background
Children who initiated early antiretroviral therapy (ART) are potential candidates for ART-free virological control. Low antibody responses to Env (gp160, gp41) or Gag (p24) HIV proteins have been reported associated with low HIV reservoir size. This study aimed to characterize HIV protein-specific antibody and HIV reservoir size in children who initiated early ART and had sustained virological suppression.
Methods
Children aged 6-10 years who initiated ART within 6 months of age and sustained virological suppression were enrolled. HIV antibodies were detected by western blot assay (WB) to 10 proteins: Env (gp160, gp120, gp41), Pol (p65, p51, p31), and Gag (p55, p40, p24, p18) and chemiluminescent microparticle immunoassay (CMIA). HIV reservoir size was measured by tat/rev induced limiting dilution assay (TILDA) and integrated HIV DNA.
Results
Between March and April 2024, 23 children were enrolled. ART was initiated at the median (interquartile range, IQR) age of 73 (45-99) days, and 17 (74%) initiated ART within 3 months of age. The median (IQR) age was 8.4 (7.0-9.5) years, CD4+ T cells was 814 (670-1191) cells/mm3, and integrated HIV DNA was 47 (15-87) copies/106 CD4+ T cells. WBs were positive for Env in 3 (13%), Pol in 10 (44%), and Gag in 14 (61%) children. Children who had negative HIV antibody by CMIA (n=14) had no response to Env-gp160 protein (0% vs 33%, p=0.04), low response to Env-gp41 protein (0% vs 11%, p=0.39) and significantly lower response to Gag-p24 (43% vs 89%, p=0.04), as shown in Figure 1A. There was no statistically significant difference in HIV-specific antibody responses between the 11 (61%) children who had undetectable HIV reservoir by TILDA assay and the 7 (39%) children with detectable TILDA (Figure 1B). There was no statistically significant difference in HIV-specific antibody responses among children with integrated HIV DNA > or ≤ 50 copies/106 CD4+ T cells (p>0.05).
Conclusions
Children with early ART had low HIV-specific antibodies to Env. No strong association between HIV-specific antibody response by WB and HIV reservoir by TILDA or integrated HIV DNA levels was found. Identification of potential candidates for ART-free virological control should consider both HIV-specific antibody and reservoir size.